At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Sensor weardevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor
In Brief
A clinical study evaluating Sensor wear for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus. Completed, enrolled 100 participants across 3 sites.
Detailed Summary
The purpose of the study is to assess the performance of a new subcutaneous glucose sensor over a seven-day sensor life when used with currently marketed Medtronic Diabetes devices. In addition performance will be calculated for use of the new sensor with proposed new devices using new calibration algorithms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2010
First PostedApr 2010
Primary CompletionNov 2010
TodayJul 2026
First PostedApr 28, 2010
Enrollment StartApr 1, 2010
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 16.2 years ago
Interventions
Sensor weardevice
All subjects to wear sensors